Fonar - 27 Year Stock Price History | FONR

Historical daily share price chart and data for Fonar since 1993 adjusted for splits. The latest closing stock price for Fonar as of April 03, 2020 is 14.44.
  • The all-time high Fonar stock closing price was 112.50 on March 13, 2000.
  • The Fonar 52-week high stock price is 25.25, which is 74.9% above the current share price.
  • The Fonar 52-week low stock price is 11.00, which is 23.8% below the current share price.
  • The average Fonar stock price for the last 52 weeks is 20.43.
Fonar Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 18.2884 20.1900 21.5400 11.2100 14.4400 -26.66%
2019 21.2884 21.2500 25.0700 19.2000 19.6900 -2.72%
2018 25.3970 24.3500 29.8000 20.0700 20.2400 -16.88%
2017 24.4442 19.2250 33.6000 17.4500 24.3500 27.15%
2016 18.1649 16.7800 23.7800 13.3200 19.1500 10.95%
2015 12.5383 10.2600 18.3300 9.1300 17.2600 65.96%
2014 14.4647 20.1700 26.3200 9.6700 10.4000 -50.96%
2013 8.0377 4.6000 21.2080 4.5900 21.2080 389.79%
2012 3.6961 1.7300 6.4000 1.6900 4.3300 154.11%
2011 1.8012 1.3000 2.6500 1.2600 1.7040 31.08%
2010 1.4940 1.7000 2.7200 1.0200 1.3000 -17.20%
2009 1.6153 0.9200 3.1900 0.6305 1.5700 89.16%
2008 2.4096 5.3200 5.3200 0.6651 0.8300 -84.04%
2007 6.4569 7.5000 8.1400 4.2080 5.2000 -25.71%
2006 12.2490 17.7500 20.5000 6.2500 7.0000 -58.82%
2005 29.9603 39.2500 43.0000 17.0000 17.0000 -56.69%
2004 32.0387 29.0000 42.7500 25.5000 39.2500 36.52%
2003 30.8125 26.7500 49.5000 20.2500 28.7500 7.48%
2002 30.6647 30.5000 50.2500 24.2500 26.7500 -10.08%
2001 37.9819 32.7500 62.2500 25.7500 29.7500 -9.16%
2000 57.9931 46.7500 112.5000 28.0000 32.7500 -22.49%
1999 31.3115 35.2500 75.0000 18.7500 42.2500 35.20%
1998 51.5347 70.2500 75.7500 26.5000 31.2500 -57.48%
1997 71.3014 56.2500 99.2500 54.0000 73.5000 25.64%
1996 61.5492 66.5000 75.7500 53.0000 58.5000 -12.03%
1995 68.0397 47.7500 100.0000 41.5000 66.5000 33.00%
1994 43.3462 54.0000 64.0000 31.2500 50.0000 -7.41%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.096B $0.087B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.087B 24.52
Medtronic (MDT) Ireland $115.455B 15.52
Stryker (SYK) United States $56.067B 18.11
Boston Scientific (BSX) United States $43.352B 19.53
Baxter (BAX) United States $41.707B 25.46
Coloplast (CLPBY) Denmark $31.190B 48.13
Lonza Group Ag (LZAGY) Switzerland $30.205B 0.00
Terumo (TRUMY) Japan $25.702B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $22.826B 0.00
ResMed (RMD) United States $21.711B 37.72
Zimmer Biomet Holdings (ZBH) United States $19.136B 11.78
Smith & Nephew SNATS (SNN) United Kingdom $14.916B 0.00
Sunny Optical Technology (SNPTF) China $14.456B 0.00
Bio-Rad Laboratories (BIO) United States $10.795B 50.45
Insulet (PODD) United States $10.501B 642.46
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $7.224B 20.78
DiaSorin S.p.A (DSRLF) Italy $6.994B 0.00
GN STORE NORD (GNNDY) Denmark $6.057B 31.29
Perrigo (PRGO) Ireland $5.826B 10.62
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Haemonetics (HAE) United States $5.020B 30.90
Canopy Growth (CGC) Canada $4.821B 0.00
ICU Medical (ICUI) United States $4.255B 27.79
Quidel (QDEL) United States $3.982B 34.95
Neogen (NEOG) United States $3.497B 59.23
GW Pharmaceuticals (GWPH) United Kingdom $2.614B 0.00
Agios Pharmaceuticals (AGIO) United States $2.551B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.392B 0.00
NuVasive (NUVA) United States $2.346B 18.14
Envista Holdings (NVST) United States $2.262B 0.00
National Vision Holdings (EYE) United States $1.325B 22.32
AtriCure (ATRC) United States $1.321B 0.00
Cardiovascular Systems (CSII) United States $1.294B 0.00
TG Therapeutics (TGTX) United States $1.032B 0.00
Aurora Cannabis (ACB) Canada $1.014B 0.00
Phibro Animal Health (PAHC) United States $0.998B 19.73
NanoString Technologies (NSTG) United States $0.846B 0.00
VAREX IMAGING (VREX) United States $0.829B 17.23
DFB Healthcare Acquisitions (AHCO) United States $0.776B 139.62
Aphria (APHA) $0.772B 0.00
Cerus (CERS) United States $0.735B 0.00
Omeros (OMER) United States $0.662B 0.00
InMode (INMD) Israel $0.659B 0.00
OraSure Technologies (OSUR) United States $0.650B 80.61
Eagle Pharmaceuticals (EGRX) United States $0.617B 36.70
PetIQ (PETQ) United States $0.574B 15.61
Quanterix (QTRX) United States $0.566B 0.00
Owens & Minor (OMI) United States $0.472B 12.90
LeMaitre Vascular (LMAT) United States $0.466B 26.26
Surmodics (SRDX) United States $0.461B 52.98
Lantheus Holdings (LNTH) United States $0.443B 9.96
Vapotherm (VAPO) United States $0.381B 0.00
Meridian Bioscience (VIVO) United States $0.370B 14.91
Zynex (ZYXI) United States $0.349B 38.04
Utah Medical Products (UTMD) United States $0.328B 23.44
Organigram Holdings (OGI) Canada $0.315B 0.00
Repro-Med Systems (KRMD) United States $0.279B 175.75
Cytosorbents (CTSO) United States $0.268B 0.00
MacroGenics (MGNX) United States $0.266B 0.00
HEXO (HEXO) $0.205B 0.00
Female Health (VERU) United States $0.201B 0.00
BioLife Solutions (BLFS) United States $0.193B 118.25
InfuSystems Holdings (INFU) United States $0.178B 148.33
Viemed Healthcare (VMD) United States $0.177B 20.00
Exagen (XGN) United States $0.161B 0.00
United Health Products (UEEC) United States $0.134B 0.00
Rockwell Medical (RMTI) United States $0.131B 0.00
Bovie Medical (APYX) United States $0.128B 0.00
Evolus (EOLS) United States $0.127B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.114B 0.00
Liberty Health Sciences (LHSIF) Canada $0.106B 0.00
Chimerix (CMRX) United States $0.085B 0.00
Brainsway (BWAY) Israel $0.081B 0.00
MTech Acquisition (KERN) United States $0.070B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.064B 0.00
United-Guardian (UG) United States $0.059B 12.45
Nephros (NEPH) United States $0.055B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.044B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.030B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00